Who is sponsoring NCT03983941?

NCT03983941 is sponsored by Sujana Dontukurthy.

What drugs are being tested in NCT03983941?

Interventions in NCT03983941: Ropivacaine injection.

What condition does NCT03983941 study?

NCT03983941 studies Anterior Cruciate Ligament Tear.

Is NCT03983941 still recruiting?

NCT03983941 is currently terminated. Last updated 16 September 2021.

Are results published for NCT03983941?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-09-16 · How we verify

NCT03983941

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IPACK Versus Popliteal Sciatic Nerve Block in ACL Reconstruction

Terminated Phase 3 Results posted Last updated 16 September 2021

What this trial tests

Phase 3 trial testing Ropivacaine injection in Anterior Cruciate Ligament Tear in 7 participants. Terminated before completion.

Timeline

30 August 2019

Primary endpoint
7 November 2019

7 November 2019

Quick facts

Lead sponsor	Sujana Dontukurthy
Phase	Phase 3
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	7
Start date	30 August 2019
Primary completion	7 November 2019
Estimated completion	7 November 2019
Sites	1 location across United States

Drugs / interventions tested

Ropivacaine injection — full drug profile →

Conditions studied

Anterior Cruciate Ligament Tear — all drugs for Anterior Cruciate Ligament Tear →

Sponsor

Sujana Dontukurthy

Who can join

Under 21, any sex, with Anterior Cruciate Ligament Tear. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Average Post-operative Pain Score Primary · Immediately post-operatively and up to 48 hours post-discharge, an average of 48 hours

Visual Analogue Scale (VAS) pain scores (0 being no pain and 10 being worst pain) from arrival to post-anesthesia care unit (PACU) to 48 hours after discharge from surgery center.

Group	Value	95% CI
FNB-AC + Sciatic Nerve Block	4.7	± 3.368
FNB-AC + IPACK	4	± 2.905

Number of Opioid Doses Administered Secondary · Intra-operative and up to 48 hours post-discharge, an average of 48 hours

Number of doses of narcotic pain medicine administered during surgery and up to 48 hours after discharge from surgery center.

Group	Value	95% CI
FNB-AC + Sciatic Nerve Block	5.5	4 – 7
FNB-AC + IPACK	3.8	2 – 5

Sponsor's own description

This is a prospective study comparing femoral nerve block plus sciatic nerve block to femoral nerve block plus infiltration of the posterior knee capsule (IPACK) in patients undergoing arthroscopic anterior cruciate ligament reconstruction. Femoral nerve block via the adductor canal (FNB-AC) with IPACK may provide effective analgesia while avoiding the motor block involved with sciatic nerve block. The lack of motor block is important to facilitate postoperative ambulation and physical therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ropivacaine injection

Trials testing the same drug.

NCT06299137 — Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures · EARLY_PHASE1 · completed
NCT05889741 — Combining Stellate Ganglion Block With Prolonged Exposure for PTSD · Phase 2 · recruiting
NCT06189781 — Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy · Phase 4 · recruiting
NCT06288841 — Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in · NA · unknown
NCT06048874 — FNB in ACL Recon Under SA · NA · not yet recruiting

Other recruiting trials for Anterior Cruciate Ligament Tear

Currently open trials in the same condition.

NCT05174611 — Vitamin D to Improve Quadricep Muscle Strength · Phase 2 · recruiting
NCT06664047 — Over-the-Top vs. Anteromedial ACLR With Lateral Extraarticular Tenodesis · NA · recruiting
NCT06511232 — Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction · Phase 4 · recruiting
NCT06524349 — Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following AC · NA · active not recruiting
NCT06353503 — Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03983941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sujana Dontukurthy
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03983941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing